On the morning of May 15, 2025, the Zhangjiang China Pharma Valley Conference Room hosted a review panel led by the Pudong New Area Science and Technology Commission to evaluate the digital transformation achievements of Shanghai Lishan Bio.
As time passes, magnificent chapters are born, and in the pleasant spring scenery, good news spreads. On May 9, 2025, Dr. Chen Weijie, Chairman of Lishan Bio, was awarded the VBEF Annual Innovative Entrepreneur Award.
On the afternoon of March 21, 2025, Dr. Chen Weijie, Chairman of Shanghai Lishan Biomedical Co., Ltd. and Dr. Zhu Chaoyu, General Manager of Fojann Intelligence (Shanghai) Pharmaceutical Co., Ltd. were invited to the Punan Branch of Renji Hospital af
The inflammatory bowel disease (IBD) pipeline of Shanghai Lishan Biomedicine Co., Ltd. has completed all the preparatory work for the previous FDA application, and will carry out the IND application of FDA in November this year, fully opening a new c
On August 27, 2024, on the occasion of the first anniversary of the Joint Laboratory of Intelligent Microbiome jointly established by Lishan Biomedicine Co., Ltd. and Fudan University, Zhuang Kesing, director of Lishan Biological Advisory Committee,
Dr. Li Changqing Hello, it is a great pleasure to welcome you to Lishan. Today we have a short interview to talk about your views as a former FDA Senior medical reviewer on the clinical trials of viable drugs. Can you describe the specificity of the